GXP-PHARMA SUPPORT ApS: Financial statements 2023
CVR: 36033347
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 360,871 and a net result of DKK 367,356 compared with DKK -345,549 the year before. That is an increase of 70.9% compared with the year before. Equity in the 2023 report amounted to DKK 1,139,676. The solvency ratio was 77%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 360,871
- Profit/Loss
- DKK 367,356
- Equity
- DKK 1,139,676
- Total Assets
- DKK 1,480,581
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 361 t. | 367 t. | 1.1 mio. | 1 |
| 2022 | - | 211 t. | -346 t. | 772 t. | 1 |
| 2021 | - | 1.1 mio. | 426 t. | 1.1 mio. | 1 |
| 2020 | - | 1 mio. | 664 t. | 1.7 mio. | 1 |
| 2019 | - | 1.2 mio. | 328 t. | 1.4 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GXP-PHARMA SUPPORT ApS has published its annual report for 2022. Gross profit came to DKK 211,195, and the net result was DKK -345,549.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The board consists of Jan Laursen (chair), Iben Cleveland Laursen and Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.